Expression of ER, PR, HER2, and Cadherin tumor markers in a series of Saudi patients with BC.
Sign Up to like & getrecommendations! Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202205_28849
Abstract: OBJECTIVE Breast cancer (BC) tumor markers have an important implication in the subsequent BC management and survival determinants. Thus, the present study aimed to formulate the expression of ER, PR, HER2, and E-cadherin tumor markers… read more here.
Keywords: saudi patients; expression her2; tumor markers; her2 cadherin ... See more keywords